Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4146920-A4146920, November 12, 2024. Cox regression results showed that there is an increased risk of mortality in patients who did not receive transfusions before transplant (p<0.0001).Conclusion:While

Transplant 40

Transplant Heart Transplant Risk Factors Outcomes 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4144084-A4144084, November 12, 2024. Despite being a heart transplantation candidate, she declined revascularization and sought alternative treatments for angina, dyspnea, and daily activity limitations. The patient underwent EECP, consisting of 35 one-hour sessions over seven weeks.

Heart Transplant 40

Heart Transplant Transplant Angina Heart Failure 40

Nature Reviews - Cardiology

JANUARY 22, 2024

Nature Reviews Cardiology, Published online: 23 January 2024; doi:10.1038/s41569-024-00991-6 Heart valve replacement in newborn babies remains an unsolved problem because currently used heart valve implants do not grow. This lack of implant growth mandates serial re-operations until adult-size valve implants can be fitted.

Heart Transplant 40

Heart Transplant Heart Valves Transplant 40

Circulation: Cardiovascular Imaging

JANUARY 15, 2024

Circulation: Cardiovascular Imaging, Volume 17, Issue 1 , Page e015858, January 1, 2024. BACKGROUND:Advanced chronic kidney disease is associated with high cardiovascular risk, even after kidney transplant. years post-transplant. An abnormal MPI result was defined as a total perfusion deficit >5% of the myocardium.

Transplant 40

Transplant Coronary Artery Disease Myocardial Infarction Kidney Disease 40

HCPLive

AUGUST 23, 2024

The third quarterly issue of 2024 reviews early versus late ERCP outcomes post-transplant, the impact of GLP-1RA use on endoscopic management, and the differential diagnosis of seronegative villous atrophy.

Transplant 105

Transplant Outcomes 105

Circulation

OCTOBER 20, 2024

Circulation, Volume 150, Issue 17 , Page 1313-1314, October 22, 2024.

Heart Transplant 45

Heart Transplant Transplant Circulation 45

DAIC

MAY 31, 2024

By the end of the study cardiologists performed 10% fewer biopsies in the first year post-transplant and 40% fewer in the second year post-transplant despite an increase in follow-up biopsy rates for dual positives. Hanna , CareDx President and CEO.

Heart Transplant 105

Heart Transplant Transplant Outcomes 105

DAIC

JANUARY 11, 2024

In organ transplantation, an extended criteria donor is defined as having perceived risk factors linked to poor subsequent outcomes, for example, those with age >55 or ischemic times exceeding 4 hours, which sometimes leads to rejection of the donor organ. utilizing the Paragonix SherpaPak CTS (p=0.022).

Transplant 111

Transplant Heart Transplant Technology Risk Factors 111

Cardiology Update

APRIL 9, 2024

The American College of Cardiology (ACC) held its 73 rd annual scientific session and expo April 6-8, 2024 in Atlanta, Georgia. The primary endpoint was a composite of all-cause mortality, left ventricular assist device (LVAD)/heart transplantation, HF hospitalizations, worsening HF, and KCCQ score changes. April 6, 2024.

Myocardial Infarction 52

Myocardial Infarction Angina Aortic valve Coronary Artery Disease 52

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4146823-A4146823, November 12, 2024. Heart transplant rates were low but increased slightly in 2020 for patients without CHD, with DV and SV CHD patients showing fluctuating rates peaking in 2018 and 2019, then declining in 2020. Patients without CHD were older (mean age 71.5

Cardiogenic Shock 40

Cardiogenic Shock Congenital Heart Disease Heart Failure Congenital 40

Circulation

MAY 19, 2024

Circulation, Volume 149, Issue 21 , Page 1667-1669, May 21, 2024.

Heart Transplant 53

Heart Transplant Transplant Circulation 53

The American Journal of Cardiology

AUGUST 27, 2024

Publication date: Available online 27 August 2024 Source: The American Journal of Cardiology Author(s): Rishabh Tandon, Dzhalal Agakishiev, Rebecca L. Freese, Julie Thompson, Prabhjot S.

Coronary Artery Disease 40

Coronary Artery Disease Transplant 40

The American Journal of Cardiology

JULY 24, 2024

Publication date: Available online 23 July 2024 Source: The American Journal of Cardiology Author(s): Giulio Cacioli, Michele Ciabatti, Ernesto Cristiano, Claudia Notari, Ilaria Papisca, Giada Distefano, Giovanni Menafra, Paola Lilla Della Monica, Mariano Antonio Feccia, Amedeo Pergolini, Viviana Maestrini, Fabio Sbaraglia, Federico Ranocchi, Francesco (..)

Heart Transplant 52

Heart Transplant Transplant 52

Circulation

JANUARY 28, 2024

Circulation, Volume 149, Issue 5 , Page 339-341, January 30, 2024.

Heart Transplant 81

Heart Transplant Transplant Pediatrics Circulation 81

DAIC

FEBRUARY 21, 2024

Getty Images milla1cf Wed, 02/21/2024 - 19:10 February 21, 2024 — Ochsner Children's Hospital , ranked among the top hospitals in the nation for pediatric cardiology and congenital heart surgery, is raising awareness of the need for more pediatric-specific heart devices. Yet, research and innovation in this field has not kept pace.

Pediatrics 105

Pediatrics Hospital Heart Failure Transplant 105

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4142247-A4142247, November 12, 2024. Background:Cardiac transplantation remains the single most effective treatment for end-stage heart failure. Autoradiography revealed68Ga-grazytracer accumulation in the transplanted heart. at POD 7 days; P<0.001).

Transplant 40

Transplant Heart Failure Circulation Outcomes 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4113494-A4113494, November 12, 2024. End-stage ischemic heart disease necessitates heart transplantation, and emerging cell therapy presents a promising solution to address donor scarcity.

Ischemia 40

Ischemia Transplant Heart Transplant Biomarkers 40

Cardiology Update

APRIL 25, 2024

The primary endpoint was a composite of all-cause mortality, left ventricular assist device (LVAD)/heart transplantation, HF hospitalizations, worsening HF, and KCCQ score changes. Learn more about the highlights from ACC 2024. Presented at: ACC 2024. April 6, 2024. April 6, 2024. Reference: Stone GW. Atlanta, GA.

Heart Failure 98

Heart Failure Heart Transplant Transplant Research 98

DAIC

JUNE 24, 2024

Photo by Cedars-Sinai milla1cf Mon, 06/24/2024 - 20:17 June 24, 2024 — Aakriti Gupta, MD , and Michelle Kittleson, MD, PhD , cardiologists in the Smidt Heart Institute at Cedars-Sinai , have been selected to join the senior editorial team of the Journal of the American College of Cardiology (JACC), effective July 1.

Heart Failure 100

Heart Failure Transplant Research Interventional Cardiology 100

The American Journal of Cardiology

JULY 6, 2024

Publication date: Available online 6 July 2024 Source: The American Journal of Cardiology Author(s): Jacob Agronin, Meredith Brown, Hannah Calvelli, Huaqing Zhao, Val Rakita, Yoshiya Toyoda, Mohammed Abul Kashem

Heart Transplant 40

Heart Transplant Transplant Outcomes 40

DAIC

APRIL 30, 2024

Image courtesy of Hideki Kobayashi from Shinshu University milla1cf Tue, 04/30/2024 - 12:53 April 30, 2024 — Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart to recover lost function. However, the risk of arrhythmias following this procedure is reportedly high.

Transplant 105

Transplant Heart Transplant Myocardial Infarction Heart Attack 105

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4145296-A4145296, November 12, 2024. Aortic valve stenosis (AS) is often a contraindication to liver transplantation (LT). Aortic valve peak velocity (AVVmax) increased steadily as patients neared transplant and dropped significantly immediately after transplantation (Figure 1A).

Aortic valve 40

Aortic valve Aortic Transplant Stenosis 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4144461-A4144461, November 12, 2024. Introduction:Left ventricular assist devices (LVADs) have become an increasingly common treatment option for patients with advanced heart failure, serving as either a bridge to transplantation or destination therapy.

Transplant 40

Transplant Risk Factors Heart Failure Circulation 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page ASa1109-ASa1109, November 12, 2024. We assessed the correlates of predicted peak VO2, and the relationship between predicted peak VO2quartiles and cardiovascular outcomes (death/transplant).Results:Of Results:Of 323 patients (age 29±9 years; 177 [55%] men), the median peak VO2 was 19.1

Transplant 40

Transplant Outcomes Exercise Cardiovascular Disease 40

The American Journal of Cardiology

JULY 31, 2024

Publication date: Available online 31 July 2024 Source: The American Journal of Cardiology Author(s): Shafaqat Ali, Manoj Kumar, Sanchit Duhan, Yehya Khlidj, Hafiz Muhammad Waqar Younas, Faryal Farooq, Bijeta Keisham, Pramod Kumar Ponna, Michael Sewell, Vijaywant Brar, Steven R Bailey, Timir K Paul, Tarek Helmy

Aortic valve 40

Aortic valve Transplant Aortic 40

DAIC

APRIL 16, 2024

milla1cf Tue, 04/16/2024 - 12:35 April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional data, including the publication of results of the post-market phase of the BeAT-HF trial in the European Journal of Heart Failure. See more details at TCTMD.

Heart Failure 104

Heart Failure Quality of Life Transplant Heart Transplant 104

Circulation: Cardiovascular Imaging

JANUARY 15, 2024

Circulation: Cardiovascular Imaging, Volume 17, Issue 1 , Page e016408, January 1, 2024.

Transplant 40

Transplant Cardiovascular Imaging Circulation 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP286-ATP286, February 1, 2024. Introduction:Intraparenchymal stem cell transplantation shows therapeutic promise for chronic ischemic stroke patients. Visium identified specific gene clusters for the stroke injury, transplant/needle-track, stem cell graft, and the cortical ‘FLAIR’ region.

Strokes 40

Strokes Stroke Transplant Research 40

DAIC

MAY 15, 2024

milla1cf Wed, 05/15/2024 - 08:50 May 15, 2024 — The U.S. 882 Dates Distributed: March 1, 2021 to present Date Initiated by Firm: March 13, 2024 Device Use The HeartMate 3 Left Ventricular Assist System (LVAS) is used to help the heart pump blood when it is not able to do so effectively on its own.

Transplant 105

Transplant Heart Failure Heart Transplant Pediatrics 105

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP42-ATP42, February 1, 2024. Stem cell transplantation enhances stroke recovery. While promising, the treatment efficacy of stem cell transplantation is restricted by inadequate stem cell survival and insufficient trophic factor release at the stroke site.

Strokes 40

Strokes Stroke Transplant 40

HeartRhythm

FEBRUARY 29, 2024

In the editorial commentary titled “Is more, “more” when itcomes to pacing in heart transplant patients?” Rod Gimbel published in February 2024 (2024;21;161-162) in Heart Rhythm, the surname of the related article’s first author, Zain Gowani, is incorrectly referred to as Gowali. This has been corrected in the online journal.

Heart Transplant 40

Heart Transplant Heart Rhythm Transplant 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4134590-A4134590, November 12, 2024. The association between a lower rate of MAE and EMB persisted in the multivariate model when those with heart transplant who had EMB were compared to those without heart transplant who did not have EMB p=0.001.

Cardiomyopathy 40

Cardiomyopathy Pediatrics Heart Transplant Heart Failure 40

DAIC

APRIL 15, 2024

Image courtesy of Abbott mtaschetta-millane Mon, 04/15/2024 - 09:54 April 15, 2024 — The U.S. 13,883 Date Initiated by Firm: February 19, 2024 Device Use The HeartMate II and HeartMate 3 Left Ventricular Assist Systems (LVAS) are used to help the heart pump blood when it's not able to do so effectively on its own.

Transplant 105

Transplant Heart Transplant Pediatrics Heart Failure 105

DAIC

NOVEMBER 13, 2024

tim.hodson Wed, 11/13/2024 - 14:27 Nov. 13, 2024 – A recent study has demonstrated the value of the single-exposure dual-energy X-ray detector in advancing cardiovascular risk assessment. In this study, researchers observed 61 bone marrow transplant patients selected for their higher cardiac complication risk.

Heart Disease 59

Heart Disease Coronary Artery Disease Technology Transplant 59

DAIC

FEBRUARY 2, 2024

9-11, 2024. Image courtesy: Getty Images christine.book Fri, 02/02/2024 - 11:35 February 2, 2024 — The American College of Cardiology ’s Cardiac Oncology Conference, “ Advancing the Cardiovascular Care of the Oncology Patient ,” will be held in person at the Heart House in Washington, D.C.,

Cardio Oncology 95

Cardio Oncology Cancer Pharmacology RN 95

Cardiology Update

JANUARY 22, 2024

The primary outcome was death from any cause, and the secondary outcome included a composite of death, heart transplantation, or ventricular assist device implantation. N Engl J Med 2024; 390:212-220. Long-term outcomes were assessed at the eight highest-enrolling sites. In the RAFT trial, 1798 patients were enrolled by February 2009.

Heart Failure 115

Heart Failure Defibrillator Heart Transplant Transplant 115

DAIC

FEBRUARY 22, 2024

Photo courtesy of The Ohio State University Wexner Medical Center milla1cf Thu, 02/22/2024 - 13:45 February 22, 2024 — About 1 in 250 Americans have dilated cardiomyopathy (DCM), a type of inherited heart muscle disease that can cause heart failure at a young age. heart failure/heart transplant programs that contributed to the study.

Heart Failure 104

Heart Failure Sudden Cardiac Death Heart Transplant Cardiomyopathy 104